FDA Investigator Margaret M Sands

Margaret M Sands has inspections in 7 countries as of 03 Nov 2023. Margaret M Sands has collaborated with a combinined 5281 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
172
Last Inspection Date:
03 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
100005721
Country:
United States of America, Korea (Republic of), Germany, India, Canada, Italy
Co-Investigator(s):
Abby E Pelletier, Abhishek Sahay, Addam S Reynolds, Adetutu M Gidado, Alberto A Viciedo, Alice S Tsao, Allen Lou, Amber G Wardwell, Amy C Jordan, Amy Chen, Amy L Singer, Amy M Cramer, Amy N Chen, Anastasia I Offordile, Angela J Davis, Ankur C Patel, Anna Kevilag, Anna Kwilas, Annemarie B Randow, Annemarie Bodnar, Anthony C Warchut, Antoinette L Ravelli, Arie C Menachem, Ariel Cruz Figueroa, Arindam Dasgupta, PhD, Ashutosh Rao, PhD, Atul J Agrawal, Barbara J Wilimczyk, Barbara Jwilimczyk Macri, Bijoy Panicker, Byungja E Marciante, Carol A Robles, Carrie A Hughes, Cary Greene, Cassandra L Abellard, Charisse K Green, Charles J Chacko, Charles M Edwards, Christina N Maurino, Christine M Smith, Christopher Janik, Chunsheng Cai, PhD, Colin E Tack, Daniel J Grabicki, Daniel L Zheng, Darin S Wiegers, Darren S Morgan, David A Oluwo, David H Smith, David P Vanhouten, David Van Houten, Dawn L Wydner, Deborah B Nixon, Demitria J Xiradakis, Denise M Digiulio, Denise M Visco, Investigator, Denm Digiulio, Devon Jenkins, Diane C Thibodeau, Dien N Nguyen, Dipesh K Shah, Donald C Obenhuber, PhD, Donald L Lech, Doreen P Gubbay, Dorothy J Denes, Douglas C Kovacs, Dr. Robert C Horan, MD, E Sngching Hwang, Edmund F Mrak, Jr, Edward J Janik, Eileen A Liu, Elizabeth Ll Edwards, Emest F Bizjak, Emily A Walters, Emmanuel J Ramos, Eric M Silberhorn, Eric Rothschild, Erik W Koester, Erin D Mccaffery, Ernie F Bizkaj, Esteban Beltran, Ferderick Razzaghi, Frank J Marciniak, Frank P Hurst, Frederick Razzaghi, Gabrielle J Swain, Ganesh N Joshi, Gary J Hagan, Gary T Greco, George Pyramides, Gerard D Difiore, Gobiga Vanniyasingam, Guerlain Ulysse, Haley H Seymour, Hang N Guo, Harlan J Howard, Harperd, Helen B Ricalde, Holly M Zahner, Jacqueline A Shaughnessy, PhD, Jacqueline S Warner, James A Liubicich, James R Birkenstamm, James W Whitney, Jay B Shah, Jay T Wong, Jayaleka J Amarasinghe, Jean Blackston Hill, Jean M Kelahan, Jeffrey J Ebersole, Jennifer Macmillan, Jessica M Monteiro, Jo Annc Declement, Joanne Heim, John A Sciacchitano, John P Mistler, John P Shelton, John S Hartford, Jonah S Ufferfilge, Jonathan G Matrisciano, Jonee J Mearns, Jose E Melendez, DDC, Jose M Cayuela, Jose O Hernandez, Josh Renzon Ramilo, Joshua C Schafer, Joy Rkozlowski Klena, Juanita P Versace, Judith A Jones, Judith A Paterson, Justine M Corson, Justine Tomasso, Kara A Scheibner, PhD, Karen A Briggs, Karen E D'orazio, Karen F Tomaziefski, Karen M Ferguson, Karishma G Gopaul, Karishma Gopaul, Karl Auguste, Katherine L Huebner, Keith M Reilly, Kelli F Dobilas, Kelly I Anderson, Kenneth M Gordon, Kent A Conforti, Kevin A Gonzalez, Kevin Obrien, Kevin P Foley, Kim Lthomas Cruse, Kimberly L Schultz, Kinh Q Mac, Ko U Min, Kristen E Rescigno, Kristina L Conroy, Kristy A Zielny, Krystyna M Kitson, Larry K Austin, Lata C Mathew, PhD, Lauren L Vajo, Laurie B Frazier, Lawrence Harmon, Jr, LCDR Debra Emerson, LCDR Wilfred A Darang, Leanna M Slarsky, Li Li, Linda Thai, Lisa Mathew, Loretta Nemchik, Lori M Newman, Louis Christy, Luella J Rossi, Luis M Burgos Medero, M Patriciaurphy Murphy, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marea K Harmon, Margaret Sand, Maria A Bienkowski, Maria A Reed, Maria Estrella, Mark R Mcclain, Marlene L Davis, Martin K You, Mary Jeanet Mcgarry, Matthew C Watson, Maura Rooney, Maya M Davis, Megan A Haggerty, Melissa B Libby, Melissa T Roy, Meredith L Sheridan, Meyer J Slobotsky, Michael P Anthony, Michael P Sheehan, Michael R Klapal, Michael Rosner, Michael Serrano, Michael Shanks, MS, Michelle A Marsh, Michelle L Johnson, Michelle M Noe, Michelle M Parisi, Mihaly S Ligmond, Mike M Rashti, Mina D Ahmadi, Mindy M Chou, Mohsen Rajabi Abhari, FDA, Monika Borkowska, Morea K Harmen, Nancy L Rolli, Nancy M Espinal, Nealie C Newberger, Neil J Bonzagni, PhD MPH, Nerizza B Dalena, Nerizza B Guerin, Nicholas A Violand, Nikki S Ramirez, Nimmy Mathews, Nina Yang, Odera I Ekwunife, Omotunde O Osunsanmi, Paraluman S Leonin, Paul L Bellamy, Paul Mouris, Paula M Laplant, Peter R Lenahan, Phares O Okelo, Philip Kreiter, Phillip E Mclaughlin, Pushpa S Jayasekara, Puspa Suresh Jayasekara, Rachael O Oyewole, Ramon E Martinez, Rapti D Madurawe, Raymond L Cheung, Rebecca E Cluster, Rebecca Rodriguez, Regina Regina, Regina T Brown, Richard H Penta, Robert C Steyert, Robert G Ruff, Robert J Ham, Robert J Martin, Robert W Mccullough, Rochelle L Cross, Rory K Geyer, Rosario D'costa, Rose Ljean Mary, Rose Xu, Russell J Glapioin, Russell J Glapion, Ruth A Williams, Rw Mccullough, Sarah Adella Fave, Sarah Forney, Sean G Casey, Sean R Marcsisin, Sena G Dissmeyer, Seng Ching Hwang, Sherri J Liu, Shirley S Wen, Sinai Davis, Sony Mathews, Sripal R Mada, PhD, Stacey S Degarmo, Stacie A Woods, State Agency, Stephanie Mangigian, MS/OSH, RN, Stephanie T Durso, Stephen C Smith, Stephen R Souza, Sunita Pandey, Syeda N Mahazabin, Tamil Arasu, PhD, Tammy L Chavis, Tania E Vizcaino, Tara G Bizjak, Tara R Gooen, Thai T Duong, Thomas E Friel, Thomas J Arista, Tonia F Bernard, Tyanna N Hadley, Unnee Ranjan, Uttaniti Limchumroon (Tom), Victoria M Daddeo, Virgilio F Pacio, CSO, Wayne J Meyer, Whitney S Reynolds, William J Leonard, William R Chang, Xiaohan Cai, PhD, Xiaokuang Lai, PhD, Ying Zhang, Yvesna C Blaise, Yvonne Y Wu, Zachary A Bogorad, Zhongren Wu

Margaret M Sands's Documents

Publish Date Document Type Title
November, 2006 EIR Meda Pharmaceuticals, Inc. - EIR, 2006-11-07
February, 2004 EIR Able Laboratories Inc. - EIR, 2004-02-04
May, 2001 FDA 483 Hikma Pharmaceuticals USA Inc. - Form 483, 2001-05-21
July, 2002 EIR Cooper Health System IRB - EIR, 2002-07-01
June, 2004 FDA 483 Syneos Health Clinical, Inc. - Form 483, 2004-06-25
April, 2016 EIR InvaGen Pharmaceuticals, Inc - EIR, 2016-04-30
February, 2001 EIR Lucasti Christopher, D.O. - EIR, 2001-02-26
August, 2001 FDA 483 Neil Laboratories Inc. - Form 483, 2001-08-10
September, 2001 FDA 483 Airgas Usa, LLC - Form 483, 2001-09-19
February, 2019 FDA 483 GLOBAL CALCIUM PRIVATE LIMITED - Form 483, 2019-02-22
December, 2003 EIR Sterigenics U.S., LLC - EIR, 2003-12-04
August, 2018 FDA 483 Pharmasol Corporation - Form 483, 2018-09-04
March, 2013 EIR MERCK SERONO SPA - EIR, 2013-03-14
March, 2000 FDA 483 Miza Pharmaceuticals USA Inc. - Form 483, 2000-03-14
January, 2007 FDA 483 Cardinal Health Inc. - Form 483, 2007-01-11
August, 2018 EIR Trividia Manufacturing Solutions - EIR, 2018-08-24
September, 2001 EIR Airgas Usa, LLC - EIR, 2001-09-19
February, 2004 FDA 483 Able Laboratories Inc. - Form 483, 2004-02-04
May, 2001 EIR IGI, Inc. - EIR, 2001-05-30
May, 2001 EIR Hikma Pharmaceuticals USA Inc. - EIR, 2001-05-21
March, 2004 EIR Meda Pharmaceuticals Inc. - EIR, 2004-03-17
November, 2011 FDA 483 Fresenius Medical Care Holdings, Inc. - Form 483, 2011-10-28
September, 2002 EIR Siegfried USA, LLC - EIR, 2002-09-24
April, 2003 EIR Sonoco CorrFlex LLC - EIR, 2003-04-16
November, 2006 FDA 483 Meda Pharmaceuticals, Inc. - Form 483, 2006-11-07
March, 2013 FDA 483 SANUM-Kehlbeck GmbH & Co. KG - Form 483, 2013-03-26
February, 2001 FDA 483 Janssen Pharmaceuticals, Inc. - Form 483, 2001-02-15
February, 2007 FDA 483 Renaissance Lakewood LLC - Form 483, 2007-02-23
November, 2017 EIR CELLTRION PHARM, INC - EIR, 2017-11-17
September, 2007 FDA 483 Howard A. Hassman, DO - Form 483, 2007-09-26
January, 2001 FDA 483 Airgas Usa, LLC - Form 483, 2001-01-23
June, 2004 EIR Syneos Health Clinical, Inc. - EIR, 2004-06-25
February, 2002 FDA 483 Sandoz Inc. - Form 483, 2002-02-22
November, 2000 EIR Veranova, L.P. - EIR, 2000-11-30
February, 2018 FDA 483 New England Life Care, Inc. - Form 483, 2018-02-08
September, 2013 FDA 483 Purdue Pharma - Form 483, 2013-09-13
August, 2003 FDA 483 NBN Infusions Inc - Form 483, 2003-08-15
September, 2007 EIR Howard A. Hassman, DO - EIR, 2007-09-26
March, 2013 EIR SANUM-Kehlbeck GmbH & Co. KG - EIR, 2013-03-26
June, 2001 EIR Siegfried USA, LLC - EIR, 2001-06-22
January, 2002 FDA 483 Specialty Packaging LLC - Form 483, 2002-01-29
September, 2003 EIR Sterigenics US LLC - EIR, 2003-09-23
March, 2000 EIR Miza Pharmaceuticals USA Inc. - EIR, 2000-03-14
February, 2001 EIR Janssen Pharmaceuticals, Inc. - EIR, 2001-02-15
September, 2013 EIR Purdue Pharma - EIR, 2013-09-13
August, 2001 EIR Advent Pharmaceuticals Inc. - EIR, 2001-08-10
September, 2002 FDA 483 Siegfried USA, LLC - Form 483, 2002-09-24
May, 2003 EIR Colgate Palmolive Co - EIR, 2003-05-27
April, 2003 EIR Hikma Pharmaceuticals USA Inc. - EIR, 2003-04-29
March, 2000 FDA 483 Response Miza Pharmaceuticals USA Inc. - Form 483R, 2000-04-11
May, 2002 EIR Hikma Pharmaceuticals USA Inc. - EIR, 2002-05-08
September, 2001 EIR Miza Pharmaceuticals USA Inc. - EIR, 2001-09-04
September, 2017 FDA 483 Citra Labs, LLC - Form 483, 2017-09-27
July, 2018 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2018-07-18
September, 2001 FDA 483 Miza Pharmaceuticals USA Inc. - Form 483, 2001-09-04
July, 2018 FDA 483 Pfizer Laboratories Div Pfizer Inc - Form 483, 2018-07-18
September, 2001 FDA 483 Response Miza Pharmaceuticals USA Inc. - Form 483R, 2001-10-12
January, 2001 EIR Airgas Usa, LLC - EIR, 2001-01-23
July, 2002 FDA 483 Cooper Health System IRB - Form 483, 2002-07-01
January, 2003 EIR Veranova, L.P. - EIR, 2003-01-31
April, 2003 EIR Janssen Pharmaceuticals, Inc. - EIR, 2003-04-09
June, 2004 FDA 483 Response Syneos Health Clinical, Inc. - Form 483R, 2004-07-13
August, 2001 FDA 483 Response Advent Pharmaceuticals Inc. - Form 483R, 2002-01-30
October, 2001 EIR Hikma Pharmaceuticals USA Inc. - EIR, 2001-10-22
November, 2006 FDA 483 Response Meda Pharmaceuticals, Inc. - Form 483R, 2006-12-01
February, 2019 EIR GLOBAL CALCIUM PRIVATE LIMITED - EIR, 2019-02-22
March, 2001 EIR Kramer Jeffrey H MD, FACC - EIR, 2001-03-09
November, 2005 EIR CELGENE CORPORATION - EIR, 2005-11-15
July, 2000 FDA 483 IGI, Inc. - Form 483, 2000-07-05
January, 2002 FDA 483 Aloe Creme Labs - Form 483, 2002-01-16
September, 2002 FDA 483 Response Siegfried USA, LLC - Form 483R, 2002-10-09

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more